User cases on hazard and potency assessment
Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across various industries to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices.
We will provide several user cases on how the GARD assays have been used for skin sensitization testing to demonstrate:
- Hazard assessment of “difficult-to-test” samples such as complex mixtures and surfactants.
- Sensitization information for risk assessment of medical devices and solid materials.
- Potency determination for both CLP classification and product development.
The webinar should last around 30 minutes, followed by a live Q&A. If you cannot attend the live event, register now to get access to the recording of this webinar.
Dr Jenvert is responsible for managing new GARD applications and supporting customer needs with our GARD technology for skin and respiratory sensitization testing. She has extensive knowledge in biocompatibility testing of medical devices and acts as an expert in ISO/TC194 WG8, updating the standards for skin sensitization and skin irritation (ISO 10993-10 and -23).